Skip to main content
Log in

Diagnosis and Treatment of Patients with Pouchitis

  • Therapy in Practice
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Pouchitis is the most common long-term complication of ileal pouch-anal anastomosis in patients with underlying ulcerative colitis. Clinical symptoms of pouchitis are not specific, and they can be caused by other conditions such as rectal cuff inflammation and irritable pouch syndrome. Therefore, to make an accurate diagnosis, endoscopic evaluation together with symptom assessment is necessary. Among five available treat-first and test-first strategies, the initial approach with pouch endoscopy without histology was the most cost-effective strategy for the diagnosis of pouchitis. On the basis of clinical course, pouchitis can be classified into acute, relapsing and chronic forms. Pouchitis can also be classified into three categories based on the response to antibacterial therapy: (i) antibacterial-responsive; (ii) antibacterial-dependent; and (iii) antibacterial-resistant. Metronidazole and ciprofloxacin are both effective in treating acute pouchitis. Although antibacterial therapy can induce and maintain remission, probiotics such as VSL#3 can also be used as to maintain clinical remission and prevent relapse in patients with relapsing or chronic pouchitis. For patients with chronic pouchitis that is resistant to antibacterials, therapy with anti-inflammatory agents and immunomodulators is often required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1

Similar content being viewed by others

Notes

  1. Use of tradenames is for identification purposes only and does not imply endorsement.

References

  1. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856–60

    PubMed  CAS  Google Scholar 

  2. Zuccaro G, Fazio VW, Church JM, et al. Pouch ileitis. Dig Dis Sci 1989; 34: 1505–10

    Article  PubMed  Google Scholar 

  3. Fazio VW, Ziv Y, Church JM, et al. Heal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 1995; 222: 120–7

    Article  PubMed  CAS  Google Scholar 

  4. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9

    Article  PubMed  CAS  Google Scholar 

  5. Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205–29

    Article  PubMed  CAS  Google Scholar 

  6. Lohmuller JL, Perberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622–9

    PubMed  CAS  Google Scholar 

  7. Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765–7

    Article  PubMed  CAS  Google Scholar 

  8. Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322–5

    Article  PubMed  CAS  Google Scholar 

  9. Dozois RR, Goldberg SM, Rothenberger DA, et al. Workshop: pouchitis. Int J Colorectal Dis 1986; 1: 2–19

    Article  PubMed  CAS  Google Scholar 

  10. Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654–65

    Article  PubMed  CAS  Google Scholar 

  11. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcomes in 1310 patients. Br J Surg 1998; 85: 800–3

    Article  PubMed  CAS  Google Scholar 

  12. Yang T, Oresland T, Jarnerot G, et al. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996; 31: 594–8

    Article  PubMed  CAS  Google Scholar 

  13. Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740–7

    PubMed  CAS  Google Scholar 

  14. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671–7

    Article  PubMed  CAS  Google Scholar 

  15. Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261–7

    Article  PubMed  CAS  Google Scholar 

  16. Kmiot WA, Hesslewood SR, Smith N, et al. Evaluation of the inflammatory infiltrate in pouchitis with 111In-labeled granulocytes. Gastroenterology 1993; 104: 981–8

    PubMed  CAS  Google Scholar 

  17. Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167–74

    Article  PubMed  CAS  Google Scholar 

  18. Petras RE. Role of the pathologist in evaluating chronic pouchitis. In: Bayless TM, Hanauer SB, editors. Advanced therapy of inflammatory bowel disease. 1st ed. Hamilton, (ON): BC Decker, 2001: 229–32

    Google Scholar 

  19. Pemberton JH. The problem with pouchitis [editorial]. Gastroenterology 1993; 104: 1209–11

    PubMed  CAS  Google Scholar 

  20. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972–7

    Article  PubMed  Google Scholar 

  21. Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487–99

    Article  PubMed  CAS  Google Scholar 

  22. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 409–15

    Article  PubMed  CAS  Google Scholar 

  23. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8

    Article  PubMed  CAS  Google Scholar 

  24. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9

    Article  PubMed  CAS  Google Scholar 

  25. Tremaine WJ, Sandborn WJ, Wolff BG, et al. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997; 11: 1041–6

    Article  PubMed  CAS  Google Scholar 

  26. Shen B, Achkar JP, Lashner BA, et al. A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001; 7: 301–5

    Article  PubMed  CAS  Google Scholar 

  27. Gionchetti P, Rizzollo F, Venturi A, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial [abstract]. Gastroenterology 2000; 118: A1214

    Article  Google Scholar 

  28. Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40: 1474–83

    Article  PubMed  CAS  Google Scholar 

  29. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27–34

    Article  PubMed  CAS  Google Scholar 

  30. Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification, and public health prospective. In: McLeod RS, Martin F, Sutherland LR, et al., editors. Trends in inflammatory bowel disease 1996. Lancaster, UK: Kluwer Academic Publishers, 1997: 51–63

    Google Scholar 

  31. Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia (PA): WB Saunders Company, 1999: 736–47

    Google Scholar 

  32. Shen B, Lashner BA, Achkar JP, et al. Modified pouchitis disease activity index (mPDAI): a new approach to the diagnosis of pouchitis. Dis Colon Rectum. In press

  33. Shen B, Shermock KM, Achkar JP, et al. A cost-effectiveness analysis of diagnostic strategies in symptomatic patients with ileal pouch-anal anastomosis [abstract]. Am J Gastroenterol 2001; 96: A975

    Google Scholar 

  34. Ricart E, Panccione R, Loftus EV, et al. Successful management of Crohn disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 429–32

    Article  PubMed  CAS  Google Scholar 

  35. Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193–6

    Article  PubMed  CAS  Google Scholar 

  36. Mignon M, Stettier C, Philips SF. Pouchitis: a poorly understood entity. Dis Colon Rectum 1995; 38: 100–3

    Article  PubMed  CAS  Google Scholar 

  37. Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000; 119: 584–5

    Article  PubMed  CAS  Google Scholar 

  38. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497–502

    Article  PubMed  CAS  Google Scholar 

  39. Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135: 463–5

    Article  PubMed  CAS  Google Scholar 

  40. Hurst RD, Chung TP, Rubin M, et al. Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280–4

    PubMed  CAS  Google Scholar 

  41. Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46: 334–7

    PubMed  CAS  Google Scholar 

  42. Wischmeyer P, Pemberton JH, Philips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978–81

    Article  PubMed  CAS  Google Scholar 

  43. Gionchetti P, Rizzello R, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713–8

    Article  PubMed  CAS  Google Scholar 

  44. Mimura T, Rizzello R, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-17

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This manuscript in supported by an American College of Gastroenterology Clinical Research Grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bo Shen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, B. Diagnosis and Treatment of Patients with Pouchitis. Drugs 63, 453–461 (2003). https://doi.org/10.2165/00003495-200363050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200363050-00002

Keywords

Navigation